Investigation of peanut oral immunotherapy with CpG/peanut nanoparticles in a murine model of peanut allergy

Preclinical findings indicate that peanut oral immunotherapy with CpG/PN-NPs might be a valuable strategy for peanut-specific immunotherapy in human subjects.